简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2019-12-12 16:29 Seattle Genetics and Takeda Announce Additional Analyses of ADCETRIS® (Brentuximab Vedotin) ECHELON-1 and ECHELON-2 Phase 3 Clinical Trials at the 2019 ASH Annual Meeting
2019-12-12 11:56 PCI Pharma Services Announces Major Investment to Expand Development and Manufacturing Capabilities at Tredegar, UK Site
2019-12-11 16:05 Takeda Demonstrates Its Long-Standing Commitment to Advancing Treatments for Rare Bleeding Disorders with Studies Highlighting Real-World Evidence and Investigational Gene Therapy at ASH 2019
2019-12-11 11:15 Takeda to Present Results from the Phase 3 TOURMALINE-AL1 Trial of NINLARO in Patients with Amyloidosis
2019-12-10 22:46 Panda Biotech Plans the Largest Industrial Hemp Processing Facility for Fiber and Cellulose in the United States
2019-12-10 18:27 Solasia Announces License and Capital Alliance for SP-04 (PledOx®) with Maruho
2019-12-10 16:07 PanTheryx Bovine Colostrum Recognized as GRAS
2019-12-10 09:50 Elliott Statement on Alexion
2019-12-09 16:18 Galderma Investigational Therapy Nemolizumab Granted FDA Breakthrough Therapy Designation for the Treatment of Patients Suffering from Prurigo Nodularis
2019-12-06 18:53 Panasonic and KOSÉ Set to Commence Verification Test for Personalized Proposals Utilizing Snow Beauty Mirror
2019-12-06 09:33 Kyriba and Scientist.com Improve Funding of Scientific Research Through SciPay™
2019-12-06 09:31 Sensor Electronic Technology Obtains Permanent Injunction Against U.S. UV LED Companies
2019-12-06 09:28 Nanomix Receives CE Mark for Diagnostic Panel That Aids in Rapid Identification of Serious, Life-Threatening Infections
2019-12-05 15:23 Healthcare+ Expo Taiwan 2019 Exhibitor Profiles
2019-12-05 09:48 Macrogen Research Outcome from ‘GenomeAsia 100K’ Covered in Nature
2019-12-04 09:24 OPTOLANE Chooses Trustonic to Protect New Connected Medical Diagnostic Devices
2019-12-03 18:44 Gen Re and PAI Health Take Strategic Partnership to Next Level
2019-12-03 11:28 Octapharma announces the presentation of the final results from the NuProtect study of Nuwiq® (simoctocog alfa) in previously untreated patients (PUPs) at ASH 2019
2019-12-02 13:16 Investor Tej Kohli Expands ‘Venture Philanthropy’ Into 3d-printed Bionic Arms
2019-11-28 09:45 Clover Biopharmaceuticals Completes $43 Million Series B Financing

Business Wire Weibo

Press Releases

Latest Releases